PROF. Kim Wook
Department of Applied Chemistry and Biological Engineering
San 5 Woncheon-dong, Yeongtong-gu, Suwon, 443-749, Korea
Paldal Hall 501
We are intersted in research for the discovery of new target substances for thetreatment of diabetes. Recently, we report that an self assembly Hyaluronic Acid Nanoparticles (HA-NP) has therapeutic effects on Type 2 diabetes. We suggest that HA-NPs could be used to interrupt HA-CD44 interaction, leading to amelioration of insulin resistance and glycemic control...
Rimonabant was first selective CB1R antagonist as an anti-obesity agent on the premise that blocking central cannabinoid activity might reduce food intake and body weight. But unfortunately, it induced ignificant psychiatric side effects, including anxiety, depression, and suicidal ideation. Therefore they had been withdrawn from the market in 2008. However...